DSC_6774
Sunday, August 2, 2026
24.1
C
Bengaluru
Hot topics
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
Is Pharma’s Business Model like McDonald’s? ...
Is Pharma’s business model like McDonald’s? Doing things over & over again without innovation?
McDonald’s is famous for its Hamburger University, a training facility at the McDonald’s Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management.
More than 5,000 students attend Hamburger University each year and over 275,000 people have graduated with a degree in Hamburgerology.
Sound familiar? Pharma’s training has been on similar lines – hire people continuously and put them through the grind of mugging up essentials of drugs for diseases that the particular company sells.
While the McDonald’s model is ideal for its business of replication, it has outlived its utility in healthcare and drug companies are in danger of being reduced to mere suppliers of drugs to new digital platform businesses unless they learn to innovate.
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
The Paradox of Protection
In the time it takes to...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
Hot topics
Indian Pharma – The Emerging Role of Hybrid Sales Model
COVID-19 has accelerated the shift in how pharma was engaging with HCPs, professional organisations and even patients in India from a sales to more of a scientific, unbiased and balanced marketing communications. As one of the business leader from a prominent MNC said, “For the first time we are seeing a certain shift in HCP’s preference for scientific communication for innovators companies. MSLs and scientific operation teams will be playing a key role in the near future.”
Violence Against Doctors: Doctor-Patient Relationship Bruised and Battered
If a business fails, it was an idea that didn’t work. If treatment fails – it must be a botch up. A broken gadget may be beyond repair, but not a patient in a doctor’s hands. From such ungraded expectations stems the potential for things to take an ugly turn.
An unwanted profession dealing with an unwanted condition, namely Ill health:
If possible, we would wish away death and diseases, hospitals and doctors. A hospital is not a holiday resort, but it too costs money. And the scenario of an adverse outcome like death simply becomes unacceptable.
Indian Pharma Regional Performance Analysis & Summary
Overall Market Performance (IPM)• The Indian Pharmaceutical Market (IPM)...
IMS Health Market Reflection Report for August 2016
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.
Mounjaro Shows Heart-Health Benefits in Major Diabetes Study
In a significant development for diabetes and cardiovascular care,...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Big Pharma and the Obesity War – Science to Subpoenas
Two pharmaceutical giants are currently locked in a high-stakes...
Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare
Introduction
For decades, the Indian pharmaceutical industry has measured success...
Newsletter
Get important news delivered directly to your inbox and stay connected!